KPRX

Kiora Pharmaceuticals
$2.54
−$0.01 (−0.39%)Jul 27, 2026
2.0FairMoatMint rating

MoatMint rates Kiora Pharmaceuticals (KPRX) 2.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.7 out of 10.

Key metrics

The numbers that frame KPRX today
Market cap
$11.26M
P/E (TTM)
-1.0
EV / FCF
-0.1
ROIC
-94%
Div yield
0%
Debt / equity
0.0
52wk Low
$1.76
52wk High
$3.10

KPRX stock rating

How KPRX scores on quality, value, growth, momentum and financial health
2.0out of 10
Fair overallFair business, expensive priceTop 80% of ~5,000 US stocks
QualityPoor1.7/10
GrowthGood6.4/10
MomentumGood6.0/10
ValuePoor0.0/10
Financial HealthPoor1.6/10

Growth

Revenue and earnings trend for KPRX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about KPRX
Is Kiora Pharmaceuticals a good buy?
Hold. Kiora Pharmaceuticals has strong momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Kiora Pharmaceuticals is selling at a very high price.
What is the market capitalization of KPRX?
Kiora Pharmaceuticals's market capitalization is $11.26M.
What is the P/E ratio for KPRX stock?
Kiora Pharmaceuticals's current P/E ratio is -1.
What is the 52-week high for KPRX stock?
The 52-week high for Kiora Pharmaceuticals is $3.10. The current close of $2.54 is 18.1% below that high.
What is the 52-week low for KPRX stock?
The 52-week low for Kiora Pharmaceuticals is $1.76. The current close of $2.54 is 44% above that low.
Does KPRX stock pay dividends?
Kiora Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KPRX?
Kiora Pharmaceuticals's Debt / Equity ratio is 0.03.